28 related articles for article (PubMed ID: 2107297)
1. Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas.
Banyai A; Varga L; Barta A; Gopcsa L; Paloczi K
Cancer Immunol Immunother; 2004 Sep; 53(9):835-9. PubMed ID: 15052374
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum complement C4 among COVID-19 patients in Khartoum state: a case control-based study.
Yahya M; Rahamtalla YA; Mohammed Nasr N; Gorish BMT
F1000Res; 2023; 12():432. PubMed ID: 37533483
[No Abstract] [Full Text] [Related]
3. The Role of Complement System's C3 and C4 Fractions in the Pathogenesis of Uveitis.
Kambulyan L; Chopikyan A; Iritsyan S; Mkhitaryan A; Hovakimyan A
Ocul Immunol Inflamm; 2024 Apr; ():1-6. PubMed ID: 38588040
[TBL] [Abstract][Full Text] [Related]
4. C3-targeted therapy in periodontal disease: moving closer to the clinic.
Hajishengallis G; Hasturk H; Lambris JD;
Trends Immunol; 2021 Oct; 42(10):856-864. PubMed ID: 34483038
[TBL] [Abstract][Full Text] [Related]
5. Complement C3 as a drug target in periodontitis.
Wadia R
Br Dent J; 2023 Dec; 235(12):965. PubMed ID: 38102271
[No Abstract] [Full Text] [Related]
6. Status of association studies linking diabetes mellitus and periodontal disease in India.
Acharya AB; Satyanarayan A; Thakur SL
Int J Diabetes Dev Ctries; 2010 Apr; 30(2):69-74. PubMed ID: 20535309
[TBL] [Abstract][Full Text] [Related]
7. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.
Hajishengallis G; Hajishengallis E; Kajikawa T; Wang B; Yancopoulou D; Ricklin D; Lambris JD
Semin Immunol; 2016 Jun; 28(3):285-91. PubMed ID: 27021500
[TBL] [Abstract][Full Text] [Related]
8. Complement-Dependent Mechanisms and Interventions in Periodontal Disease.
Hajishengallis G; Kajikawa T; Hajishengallis E; Maekawa T; Reis ES; Mastellos DC; Yancopoulou D; Hasturk H; Lambris JD
Front Immunol; 2019; 10():406. PubMed ID: 30915073
[TBL] [Abstract][Full Text] [Related]
9. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
[TBL] [Abstract][Full Text] [Related]
10. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
[TBL] [Abstract][Full Text] [Related]
11. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
12. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
13. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
14. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis.
Anil S; Remani P; Vijayakumar T; Joseph PA
J Periodontol; 1990 Jan; 61(1):27-9. PubMed ID: 2107297
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
